The objective of this study was to study the integrated score of ST-segment resolution (ISSTE) and in-hospital death in patients undergoing primary percutaneous intervention and at 2 hours after revascularization. Results: The ISSTE score calculated at baseline, immediately before the primary percutaneous coronary intervention, was significantly higher in Group 2 as compared to Group 1 (13.9 ± 1.2 vs. 11.0 ± 0.2, p = 0.026). At the same time, the ISSTE score calculated at 2 hours after the coronary intervention was significantly higher for patients in Group 2 (7.36 ± 1.12 vs. 2.9 ± 0.1, p <0.0001). Analysis of the dynamics of the ISSTE score indicated that patients who survived presented a more expressed reduction in the ISSTE score following pPCI, as compared to those who subsequently died (73.5% reduction in Group 1 compared to 47.2% reduction in Group 2, p <0.0001). In-hospital mortality was significantly higher in the group of patients with >50% reduction in the ISSTE score. The in-hospital death rate was 5.4% in patients with >50% reduction in the ISSTE score, compared to 19.4% for those who presented less than 50% reduction in the ISSTE score following pPCI (p <0.0001).
INTRODuCTION
Early reperfusion with primary percutaneous coronary intervention (pPCI) has substantially improved outcomes for ST-elevation myocardial infarction (STEMI) patients.
However, despite the efficiency of pPCI, in-hospital mortality after acute myocardial infarction (AMI) remains high. 1 Detecting patients with an elevated risk for further events such as re-infarction or death, is necessary to initiate appropriate therapy and to reduce the risk of adverse events.
Prognostic evaluation for STEMI is far from ideal.
Therefore, an ongoing search for markers to complete the currently applied risk scores is essential. ST segment resolution after pPCI or thrombolysis is indicative for efficient reperfusion at the level of the myocardial tissue. Several studies demonstrated that in STEMI patients, reversal of ST segment elevation is a good predictor for the patency of an infarct-related artery (IRA), and is inversely correlated with subsequent death. [2] [3] [4] On the other hand, the persistence of ST segment elevation is specific for either an obstructed IRA or a patent artery, but with no myocardial and microvascular reperfusion (no-reflow phenomenon). 4 The objective of this study was to study the integrated score of ST segment resolution (ISSTE) as an indicator of ECG-based score and in-hospital death in patients undergoing pPCI for STEMI.
The null hypothesis is that there is no statistical difference between patients who die during hospitalization and those discharged alive, for integrated score of ST segment resolution.
MATERIAL AND METHODS
This prospective study included all consecutive patients admitted to the Cardiology Clinic of the County Emergen- The inclusion criteria were:
• typical chest pain lasting for more than 10 minutes, with the onset less than 12 hours before presentation;
• troponin elevation;
• ST segment elevation of more than 1 mm in two or more consecutive leads, with reciprocal ST segment depression in opposite leads;
• pPCI performed in less than 12 hours from the onset of symptoms.
The exclusion criteria were:
• patients presenting with left bundle branch block (LBBB), which precluded the correct assessment of ST elevation on the surface ECG;
• the lack of any ST segment elevation on the ECG.
All patients underwent angiographic evaluation and revascularization via pPCI.
The study protocol was approved by the ethics committee of the institution, and all patients gave written informed consent before being enrolled in the study. The study was conducted by the principles stipulated in the 
Study endpointS
The primary endpoint of the study was the all-cause mortality during hospitalization. The duration of stay in the hospital for the study population was 8.3 days (maximum), with an average of 6.5 days. All-cause mortality was recorded during this period. Only deaths that occurred during the hospitalization were included in the analysis.
The secondary endpoint of the study was the rate of successful reperfusion following pPCI, as defined by a reduction of >50% of the ISSTE at two hours after pPCI.
StatiStical analySiS
The data was statistically analyzed using GraphPad Prism 
RESuLTS
The null hypothesis of the study was rejected, as there was a significant statistical difference between the study groups in relation to the stated parameter (ISSTE resolution).
BaSeline and clinical characteriSticS
The mean population age was significantly higher in the nonsurvivor group compared to survivors (61. Table 2) .
Interestingly, higher rates of hypercholesterolemia and hypertriglyceridemia were recorded in the survivor group (Table 2) .
Serum biomarkers characterizing myocardial necrosis and renal function were significantly elevated in the survivor group compared to the nonsurvivors (creatinkinase 3,035 ± 385 mg/dl vs. 2,103 ± 89.6 mg/dl, p = 0.006, creatinine 1.4 ± 0.8 vs. 0.9 ± 0.6, p <0.0001) ( Table 3 ).
The clinical status at presentation was significantly more altered in patients who died during hospitalization compared to the survivor group, as expressed by: (1) the significantly higher incidence of Killip III and IV class in (Table 4) .
angiographic analySiS
The most frequent infarct-related artery was the left anterior descending coronary artery (LAD) in both groups, the difference between the groups being not statistically significant. (Table 5) . 
Study endpointS

In-hospital mortality
In-hospital mortality was significantly higher in the group of patients with >50% reduction in the ISSTE score. The in-hospital death rate was 5.4% in patients with >50% reduction in the ISSTE score, compared to 19.4% for those who presented less than 50% reduction in the ISSTE score following pPCI (p <0.0001) (Figure 2 ).
The mean duration of hospitalization was 6.4 days for those who survived, while in the group of patients who died, cardiac arrest occurred on average after 2.3 days following admission and pPCI.
Reperfusion rate
The rate of successful reperfusion, expressed by the reduction in the ISSTE score, was 83.8% in Group 1 compared to 55.3% in Group 2 (p <0.0001), indicating that the absence of an efficient reperfusion after pPCI is associated with a higher mortality in STEMI patients, and could be evaluated using regression of the ISSTE score.
DISCuSSIONS
Stemi mortality in the Study population
Widimsky et al. studied the reperfusion therapy for STEMI in 30 European countries, and found that the in-hospital mortality for pPCI-treated MI patients varied between 2.7% and 8%. 1 Similarly, in the present study population,
8.03% of patients died during hospitalization.
Early risk assessment is essential for STEMI patients.
Therefore, there is a clear need to develop effective tools
for assessing the risk of immediate fatal events in this patient population. This has generated the reevaluation of the prognostic usefulness of ST segment elevation decrease after STEMI.
ecg ScoreS for predicting mortality in Stemi patientS
Previous studies have evaluated the predictive ability of early ST segment resolution after thrombolytic therapy. pital mortality plus congestive heart failure (CHF). In this study, the patients were categorized into two groups, the 
clinical preSentation and Stemi mortality
A study published in 2009 concluded that after pPCI, female gender is an independent predictor of death during hospitalization. 8 However, in the current study, it was observed that there was a lower number of women in the deceased group (40.42%) than in the survival group (41.92%), though the difference was not statistically sig-
nificant. An increased glycaemia can increase the mortality risk and negatively influence prognosis in post-MI patients. Capes et al. concluded in a meta-analysis that an acute increase in blood glucose concentrations is related to a higher risk of in-hospital death in both diabetic and nondiabetic patients. 9 Also, Hsu PH et al. concluded, in a study comparing in-hospital outcome of STEMI patients with and without diabetes, that in-hospital mortality rate is higher for diabetic than nondiabetic patients. 10 There was a larger number of diabetics among deceased patients (48.93%), whereas only 21.56% of the survivors were diabetics (p <0.0001). The deceased patients also had higher blood glucose levels on admission when compared to survivors.
A study performed on 3,076 patients undergoing PCI for AMI, assessed the influence of the body mass index (BMI) on outcome, and concluded that BMI itself did not affect mortality during the hospital stay. 11 However, another study, performed on 10,534 patients from the German MITRA PLUS Registry, showed that STEMI occur at a younger age in obese individuals, and that obesity cases showed, paradoxically, the lowest in-hospital mortality from all body mass index groups (obese >30 kg/m 2 , overweight 25-29.9 kg/m 2 , average weight 18.5-24.9 kg/ m 2 ). 12 Furthermore, a study that analyzed the in-hospital prognosis of percutaneous coronary interventions in extremely obese and normal weight patients, found that extreme obesity is an independent factor for assessing in-patient mortality. 13 revealed a strong correlation connecting smoking and mortality. 15 The results of the present study showed that patients who died during hospitalization were less likely to have been active smokers.
A previous study, which aimed to determine the influence of hypertension on mortality rates after AMI, concluded that hypertension at the time of the acute coronary event is associated with higher in-hospital mortality. 16 In the present study, we found an increased incidence of hypertension in the deceased group, compared to survivors.
In the present study, in the deceased group, there was a higher percentage of patients who had a history of an- had a previous stroke (p = 0.0009).
A study of early risk stratification in STEMI patients treated with pPCI based on leucocytes count, glycaemia and creatinine on admission showed that higher death rates were noted in cases with increased creatinine (cutoff value of 1.2 mg/dl). 18 In the present study patients who died had higher levels of creatinine compared to patients who survived (1.4 ± 0.8 vs. 0.9 ± 0.6, p <0.0001). 
CONCLuSIONS
The ISSTE score is a useful ECG-derived marker of myocardial damage in STEMI patients. A high ISSTE score is associated with higher mortality, while the regression of ISSTE after pPCI could indicate an adequate reperfusion and decreased mortality in the first days after infarction.
Therefore, ISSTE could represent a simple, quick, inexpensive and effective method for categorizing patients into high and low risk of death during hospital stay following an acute myocardial infarction.
clinical implicationS
The Integrated Score of ST segment Elevation is a simple electrocardiographic tool, which can be used to stratify patients into low-and high-risk groups, according to the cut-off value of 50% ST segment resolution after revascularization. Risk stratification is essential in the management of STEMI patients, as it optimizes patient triage for appropriate treatment, and improves monitoring during hospitalization and follow-up after discharge. Furthermore, the ISSTE should be used in addition to other risk scores that include clinical, laboratory and angiographic variables, in order to best predict in-hospital events for STEMI patients following revascularization.
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